Related Experiment Videos
Is succinylcholine appropriate or obsolete in the intensive care unit?
1Institute for Anaesthesiology, University Hospital Nijmegen, Sint Radboud, Nijmegen, The Netherlands. l.booij@anes.azn.nl
Critical Care (London, England)
|December 12, 2001
Summary
Succinylcholine use in intensive care units (ICUs) is obsolete due to its adverse effects. Intermediately long-acting nondepolarizing relaxants, such as rocuronium, are recommended alternatives for intubation in ICU patients.
Area of Science:
- Critical Care Medicine
- Pharmacology
- Anesthesiology
Background:
- Muscle relaxants are crucial for intubation in intensive care units (ICUs).
- Succinylcholine, a depolarizing neuromuscular blocker, has a significant adverse effect profile.
- The use of succinylcholine in the ICU setting requires careful consideration due to safety concerns.
Purpose of the Study:
- To evaluate the current use of muscle relaxants for intubation in intensive care units.
- To assess the suitability of succinylcholine versus alternative agents.
- To recommend safer and more effective muscle relaxants for ICU intubation.
Main Methods:
- Review of current clinical practices regarding neuromuscular blocking agents in ICUs.
- Analysis of the adverse effect profiles of commonly used muscle relaxants.
- Comparison of the efficacy and safety of succinylcholine and nondepolarizing agents.
Main Results:
- Succinylcholine's adverse effect profile renders its use in the ICU obsolete.
- Intermediately long-acting nondepolarizing relaxants are identified as suitable alternatives.
- Rocuronium is highlighted as a preferable option among the alternatives.
Conclusions:
- The use of succinylcholine for intubation in intensive care units should be discontinued.
- Nondepolarizing neuromuscular blocking agents, particularly rocuronium, offer a safer alternative for facilitating intubation in critically ill patients.
- Optimizing muscle relaxant selection in the ICU is essential for patient safety and improved outcomes.